Jaipur X-Lab India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 25-06-2024
- Paid Up Capital ₹ 0.10 M
as on 25-06-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2015)
- Profit 11.88%
(FY 2015)
- Ebitda 11.88%
(FY 2015)
- Net Worth -3.11%
(FY 2015)
- Total Assets -0.07%
(FY 2015)
About Jaipur X-Lab India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Jandani, Anish Maru, Sanjay Saxena, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232RJ2009PTC030493
- Company No.
030493
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Dec 2009
- Date of AGM
30 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Jaipur X-Lab India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Jandani  | Director | 31-Mar-2018 | Current |
| Anish Maru | Director | 14-Dec-2009 | Current |
| Sanjay Saxena | Director | 31-Mar-2018 | Current |
| Shail Maru | Director | 14-Dec-2009 | Current |
Financial Performance and Corporate Structure Insights of Jaipur X-Lab India.
Jaipur X-Lab India Private Limited, for the financial year ended 2015, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 11.88% increase in profit. The company's net worth dipped by a decrease of 3.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jaipur X-Lab India?
In 2017, Jaipur X-Lab India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maru Healthcare Private Limited
Active
17 years 6 months Manoj Jandani, Anish Maru and 2 more are mutual person
Phoenix Clinical Research Services Private Limited
Active 16 years 2 months Manoj Jandani, Anish Maru and 2 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Jaipur X-Lab India?
Unlock and access historical data on people associated with Jaipur X-Lab India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jaipur X-Lab India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jaipur X-Lab India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
